KOR ENG

First-In-Class Medication Pioneer

Excellence through

WITHeranostics

Discover our Science
What We Do

Our Science

Learn more

We develop bio-medicine with new mechanisms of action
to fulfill the advanced hope drug needs of patients.

About
MirimGENE

MirimGene is a bio venture company that develops first-in-class innovative drugs for the treatment of
intractable infections and immune diseases by targeting the endogenous innate immune activation
factors that we have discovered and introduced new to the world by elucidating its mechanism of action.

Stay in Touch

Recent News

View more
MirimZINE

Enzaim Healthcare IR communication seminar

MirimGENE participated in Enzaim Healthcare's IR seminar at Seoul Square on July 24th. During t...

MirimZINE

ASK symposium presentation

Dr. Mirim Jin, the CEO, was in attendance at The Antibody Society Korea 2023 Summer Symposium, which...

MirimZINE

KDDF Young BD workshop

On June 21–22, MirimGENE attended the 2023 KDDF Young BD workshop. In the workshop, BD expert...

MirimZINE

MirimGENE at BIO USA 2023

MirimGENE attended BIO USA 2023 in Boston from June 5th to 8th.MirimGENE was chosen as the presentin...